The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider O'loughlin Steve since year 2005.
The trader's CIK number is 1615840.
At the time of this reporting, O'loughlin Steve is the Principal Financial Officer of Actinium Pharmaceuticals, Inc. .
(stock ticker symbol ATNM).
See this page for all insider trading activities at Actinium Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-10||ATNM||Actinium Pharmaceuticals, Inc.||Buy||10,000||.43||4,350|
|2018-06-15||ATNM||Actinium Pharmaceuticals, Inc.||Buy||12,000||.50||6,000|
|2017-06-15||ATNM||Actinium Pharmaceuticals, Inc.||Buy||3,500||1.17||4,094|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'loughlin Steve (Principal Financial Officer of Actinium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.